The Deep Sea Fish Oil Soft Capsule segmentation by application delineates four principal demand drivers that together shape market size. Cardiovascular health accounts for the largest share, roughly 40 % of total volume, as clinicians prescribe omega‑3s to manage triglyceride levels and support heart rhythm stability. Cognitive support follows with an estimated 25 % share, reflecting growing consumer awareness of DHA’s role in brain function, memory retention, and age‑related neuro‑degeneration mitigation. Joint and inflammation represents about 20 % of the market, driven by evidence linking EPA to reduced arthritic pain and systemic inflammatory markers. Finally, general wellness occupies the remaining 15 %, encompassing consumers who adopt fish‑oil capsules for overall nutrient adequacy without a specific therapeutic target. Each application segment contributes distinct revenue streams, influencing formulation focus, labeling claims, and distribution channels, thereby collectively defining the overall market footprint.